AC Immune (ACIU) Short-term Investments (2018 - 2025)

AC Immune (ACIU) has 8 years of Short-term Investments data on file, last reported at $80.8 million in Q4 2025.

• Quarterly Short-term Investments fell 45.21% year-over-year to $80.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $80.8 million (down 45.21% YoY) and the FY2025 annual result came in at $77.9 million, down 47.18% from the prior year.
• Short-term Investments slipped to $80.8 million in Q4 2025 per ACIU's latest filing, from $100.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $125.8 billion in Q4 2021 and bottomed at -$32.9 million in Q2 2021.
• The 5-year median for Short-term Investments is $87.6 million (2022), against an average of $9.9 billion.
• Peak annual rise in Short-term Investments reached 174868.07% in 2021, while the deepest fall reached 417.01% in 2021.
• Tracing ACIU's Short-term Investments over 5 years: stood at $125.8 billion in 2021, then tumbled by 99.92% to $94.5 million in 2022, then decreased by 20.7% to $74.9 million in 2023, then soared by 96.91% to $147.5 million in 2024, then sank by 45.21% to $80.8 million in 2025.
• Per Business Quant, the three latest ACIU Short-term Investments figures stand at $80.8 million (Q4 2025), $100.9 million (Q3 2025), and $122.5 million (Q2 2025).

Peer Comparison